When an Australian tech entrepreneur with no background in biology or medication stated ChatGPT helped save his canine from most cancers, the story unfold with the type of validation Huge Tech has lengthy craved: proof that AI will revolutionize medication and tackle one in all its deadliest illnesses. The fact, as ordinary, is extra sophisticated.
The model of the story that made the rounds on-line, first reported by The Australian, was comparatively simple. In 2024, Sydney-based Paul Conyngham discovered that his canine Rosie had most cancers. Chemotherapy slowed the illness however did not shrink the tumors. After vets stated “nothing might be accomplished” for the Staffordshire bull terrier-shar pei, Conyngham stated “I took it upon myself to discover a treatment.”
Conyngham stated he used ChatGPT to brainstorm remedy concepts. The chatbot surfaced immunotherapy as an possibility and pointed him towards specialists on the College of New South Wales, who then genetically profiled Rosie’s most cancers. He then used ChatGPT and Google’s protein construction AI mannequin AlphaFold to assist make sense of the outcomes. With the assistance of UNSW professor Pall Thordarson, he pursued a customized mRNA vaccine tailor-made to Rosie’s tumor mutations. Thordarson informed The Australian he thinks it’s the primary time such a remedy has been designed for a canine.
A number of weeks after Rosie’s first injection final December, Conyngham stated her tumors had shrunk and he or she’s doing higher, even chasing rabbits within the park. They’ve not disappeared fully, although, and one tumor didn’t reply in any respect. “I’m underneath no phantasm that this can be a treatment, however I do imagine this remedy has purchased Rosie considerably extra time and high quality of life,” Conyngham informed The Australian.
That nuance was misplaced because the story unfold. Newsweek ran the headline “Proprietor With No Medical Background Invents Treatment for Canine’s Terminal Most cancers,” whereas the New York Put up declared {that a} “Tech professional saves his dying canine by utilizing ChatGPT to code a customized most cancers vaccine.” On social media, many accounts hyped Rosie’s case as a “treatment” and an indication a brand new period of personalised medication had arrived. Some, notably OpenAI president and cofounder Greg Brockman, ought to have positively recognized higher, and others, like Google DeepMind CEO Demis Hassabis, did and shared it with out hype. Elon Musk joined in too, eager to level out that xAI’s Grok additionally performed a component — a element that was absent from a lot of the unique protection.
The story additionally offers AI far an excessive amount of credit score. Not solely was Rosie not cured of most cancers, it’s not clear the mRNA vaccine was accountable for her enchancment. The personalised remedy was administered alongside one other type of immunotherapy often known as a checkpoint inhibitor, designed to assist the immune system goal tumors, making it troublesome to know if the vaccine had any impact in any respect. One of many scientists concerned, Martin Smith, stated the workforce is performing checks to verify the immune response.
ChatGPT didn’t design or create Rosie’s remedy; human researchers did.
Nor was the vaccine itself generated by a chatbot. ChatGPT didn’t design or create Rosie’s remedy; human researchers did. At most, the chatbot served as a analysis assistant serving to Conyngham parse medical literature — spectacular, however a far cry from the breakthrough implied.
Stories are additionally imprecise on AlphaFold’s position. David Ascher, a professor and director of biotechnology applications on the College of Queensland in Australia, informed The Verge that the mannequin “may contribute structural hypotheses about proteins, however it’s not a turnkey cancer-vaccine design system.” Official steerage, he famous, additionally warns that AlphaFold shouldn’t be validated for predicting the consequences of some mutations and doesn’t mannequin “a number of biologically vital contexts” both.
Grok’s contribution is even tougher to pin down. On X, Conyngham wrote that “the ultimate vaccine assemble for Rose was designed by Grok,” however it’s not clear what which means in observe or what inputs the mannequin was given. Ascher stated Grok would realistically fall into a lot the identical class as ChatGPT: a software that “may assist with literature search, summarising papers, translating jargon, suggesting workflows, drafting code or paperwork, and serving to a consumer assume via choices.” A helpful position, however hardly what designing a most cancers vaccine suggests.
The “AI made this” framing ignores this huge human effort, with out which the “AI’s output would have remained simply textual content on a display screen.”
All in all, Ascher stated Rosie’s case “is best seen as an uncommon, extremely particular proof of risk than a template odd folks can readily reproduce.” It wanted “substantial” professional labor, he stated, “not only a chatbot and some prompts.”
That distinction is particularly vital in medication, the place success relies upon not simply on producing believable data, however on the professional, bodily work of manufacturing, testing, and delivering precise remedy. Alvin Chan, an assistant professor on the Nanyang Technological College in Singapore who’s constructing AI for biomedical and drug discoveries, informed The Verge the “AI made this” framing ignores this huge human effort, with out which the “AI’s output would have remained simply textual content on a display screen.” In Rosie’s case, AI is best understood as a software for sketching a blueprint than because the creator of the remedy itself.
The entire thing carries a faint whiff of a PR stunt that’s laborious to shake. Daring claims constructed from questionable foundations utilizing imprecise strategies comfortably match contained in the world of tech fundraising. mRNA vaccines — very like the broader promise of personalised medication — stay largely unproven as most cancers therapies in people, not to mention canine, and whereas the case could also be actual, it feels too tidy and conveniently glosses over the tens of hundreds of {dollars} and important experience required to show the concept right into a viable remedy.
I reached out to Conyngham asking for a chat on X however haven’t acquired a response but. His profile says “Ending Most cancers for Canine” and hyperlinks to a Google kind describing his “dream to make this course of one thing everybody may have entry to.” The shape asks whether or not your canine has most cancers, whether or not you’re a researcher or scientist who needs to become involved, and whether or not you might be an investor.
I believe it will be a mistake to dismiss Rosie’s story as fully meaningless. AI is probably not changing the lab anytime quickly, however it’s making science extra accessible to odd folks. Nevertheless, that’s not the identical as making care extra accessible, and few sufferers — or pet homeowners — have prepared entry to the world-class specialists, specialised gear, and substantial funds wanted to show that data into actual remedy.
